zegfrovy

Frequently asked questions

What does Zegfrovy treat?

Zegfrovy (Sunvozertinib) may be used to treat non-small-cell lung carcinoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Zegfrovy?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Zegfrovy. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Zegfrovy?

Zegfrovy is marketed by Dizal Jiangsu. You can see Dizal Jiangsu's full profile, rating, and other products on pharmaranks.

Is Zegfrovy a brand-name or generic drug?

Zegfrovy is a brand-name product with the active ingredient Sunvozertinib.

Is Zegfrovy available over the counter?

No. Zegfrovy is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Zegfrovy come in?

Zegfrovy is currently marketed as tablet, per the FDA's National Drug Code Directory.

Is Zegfrovy FDA-registered?

Zegfrovy is on record with the U.S. FDA under application number NDA219839. You can verify this on its official FDA label.